Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > Good clinical update

<< Previous

Bullboard Posts

Next >>

Comment by Sunvalleyon May 31, 2023 9:08am

198 Views

Post# 35472031

RE:RE:RE:Good clinical update

Just enough cash until the FDA approval kicks in if everything goes tickety-boo and if the application is filed immediatly. Then big pharma makes a deal with TLT with the necessary cash consideration up front and we are away to the races. We shall see how good RDW is at threading the needle from this point onwards. Possible but only a news release would confirm the foregoing.

<< Previous

Bullboard Posts

Next >>

From now on, dynaCERT instead of Bitcoin or NVIDIA?